搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
12 天
How having electric currents fired into my brain cured my chronic pain
Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...
Medscape
13 天
Novel Brain Biomarker Accurately Predicts Pain Sensitivity
Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...
Discover Magazine
10 天
FDA Approves Opioid Alternative for Pain Relief That Is Non-Addictive
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
10 天
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The Week
13 天
Brain scans show mindfulness meditation can reduce pain
Researchers found that mindfulness meditation can modify how a person experiences pain in a way that uses no drugs, proving ...
10 天
on MSN
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
10 天
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
11 天
FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Medscape
11 天
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈